{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:11:12Z","timestamp":1769199072312,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National nature Science Foundation of China","doi-asserted-by":"crossref","award":["81901746"],"award-info":[{"award-number":["81901746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14034-x","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:13:20Z","timestamp":1745979200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features"],"prefix":"10.1186","volume":"25","author":[{"given":"Xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"3","key":"14034_CR1","first-page":"169","volume":"23","author":"Y Sun","year":"2020","unstructured":"Sun Y, Dai W, Liang Y, Xia N. Impact of age on the prognosis of papillary thyroid carcinoma. Arch Iran Med. 2020;23(3):169\u201374.","journal-title":"Arch Iran Med"},{"issue":"3","key":"14034_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","volume":"42","author":"Y Ito","year":"2018","unstructured":"Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma participants: A Single-Institution Long-Term Follow-up of 5897 participants. Word J Surg. 2018;42(3):615\u201322. https:\/\/doi.org\/10.1007\/s00268-018-4479-z.","journal-title":"Word J Surg"},{"issue":"1","key":"14034_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551.","journal-title":"CA Cancer J Clin"},{"key":"14034_CR4","first-page":"241","volume":"113","author":"ID Hay","year":"2002","unstructured":"Hay ID, McConahey WM, Goellner JR. Managing participants with papillary thyroid carcinoma: insights gained from Mayo clinic\u2019s experience of treating 2,512 consecutive participants during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002;113:241\u201360.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"14034_CR5","doi-asserted-by":"publisher","unstructured":"Tuttle RM, Leboeuf R, Martorella AJ. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am (2007) 36 (3): 753\u2013\u200978. doi: org\/ https:\/\/doi.org\/10.1016\/j.ecl.2007.04.004","DOI":"10.1016\/j.ecl.2007.04.004"},{"issue":"3","key":"14034_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1023\/B:BREA.0000036787.59816.01","volume":"86","author":"G Spizzo","year":"2004","unstructured":"Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, et al. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat. 2004;86(3):207\u201313. https:\/\/doi.org\/10.1023\/B:BREA.0000036787.59816.01.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"14034_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ijc.30099","volume":"139","author":"A Seeber","year":"2016","unstructured":"Seeber A, Untergasser G, Spizzo G, Terracciano L, Lugli A, Kasal A, et al. Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer. Int J Cancer. 2016;139(3):657\u201363. https:\/\/doi.org\/10.1002\/ijc.30099.","journal-title":"Int J Cancer"},{"issue":"5","key":"14034_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/bjc.2014.366","volume":"111","author":"P Massoner","year":"2014","unstructured":"Massoner P, Thomm T, Mack B, Untergasser G, Martowicz A, Bobowski K, et al. EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c\/205. Br J Cancer. 2014;111(5):955\u201364. https:\/\/doi.org\/10.1038\/bjc.2014.366.","journal-title":"Br J Cancer"},{"issue":"5","key":"14034_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.cji.0000211303.52503.da","volume":"29","author":"C Ensinger","year":"2006","unstructured":"Ensinger C, Kremser R, Prommegger R, Spizzo G, Schmid KW. EpCAM overexpression in thyroid carcinomas: a histopathological study of 121 cases. J Immunother. 2006;29(5):569\u201373. https:\/\/doi.org\/10.1097\/01.cji.0000211303.52503.da.","journal-title":"J Immunother"},{"issue":"2","key":"14034_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejso.2013.11.015","volume":"40","author":"N Batawil","year":"2014","unstructured":"Batawil N, Alkordy T. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. Eur J Surg Onco. 2014;40(2):182\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2013.11.015.","journal-title":"Eur J Surg Onco"},{"issue":"1","key":"14034_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jso.23345","volume":"108","author":"S Misra","year":"2013","unstructured":"Misra S, Meiyappan S, Heus L, Freeman J, Rotstein L, Brierley JD, et al. Participants\u2019 experiences following local-regional recurrence of thyroid cancer: A qualitative study. J Surg Oncol. 2013;108(1):47\u201351. https:\/\/doi.org\/10.1002\/jso.23345.","journal-title":"J Surg Oncol"},{"key":"14034_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.12659\/PJR.896757","volume":"81","author":"PY Marcy","year":"2016","unstructured":"Marcy PY, Thariat J, Chevenet C, Lacout A. Jugular vein invasion diagnosis and prognosis in thyroid carcinomas. Pol J Radiol. 2016;81:268\u20139. https:\/\/doi.org\/10.12659\/PJR.896757.","journal-title":"Pol J Radiol"},{"issue":"1","key":"14034_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/eje.0.1380041","volume":"138","author":"T Rago","year":"1998","unstructured":"Rago T, Vitti P, Chovato L, Mazzeo S, De Liperi A, Miccoli P, et al. Role of conventional ultrasonography and color flow doppler sonography in predicting malignancy in cold thyroid nodules. Europ J Endocrinol. 1998;138(1):41\u20136. https:\/\/doi.org\/10.1530\/eje.0.1380041.","journal-title":"Europ J Endocrinol"},{"issue":"12","key":"14034_CR14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.7863\/ultra.15.02006","volume":"34","author":"A Kamaya","year":"2015","unstructured":"Kamaya A, Tahvildari AM, Patel BN, Willmann JK, Jeffrey RB, Desser TS. Sonographic detection of extracapsular extension in papillary thyroid cancer. J Ultrasound Med. 2015;34(12):2225\u201330. https:\/\/doi.org\/10.7863\/ultra.15.02006.","journal-title":"J Ultrasound Med"},{"issue":"7","key":"14034_CR15","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1007\/s00330-020-07516-y","volume":"31","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang X, Li J, Cai Q, Song Z, Luo Y. Contrast-enhanced ultrasound: a valuable modality for extrathyroidal extension assessment in papillary thyroid cancer. Eur Radiol. 2021;31(7):4568\u201375. https:\/\/doi.org\/10.1007\/s00330-020-07516-y.","journal-title":"Eur Radiol"},{"key":"14034_CR16","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. World Health Organization (WHO) Classification of tumours of endocrine organs. 4th edition, International Agency for Research on Cancer (IARC) (Press, Lyon, France) (2017) p65\u2013142."},{"issue":"3","key":"14034_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.76.3.1438","volume":"76","author":"M Herlyn","year":"1979","unstructured":"Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979;76(3):1438\u201342. https:\/\/doi.org\/10.1073\/pnas.76.3.1438.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"14034_CR18","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1038\/sj.onc.1207610","volume":"23","author":"M M\u00fcnz","year":"2004","unstructured":"M\u00fcnz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene. 2004;23(34):5748\u201358. https:\/\/doi.org\/10.1038\/sj.onc.1207610.","journal-title":"Oncogene"},{"issue":"9","key":"14034_CR19","doi-asserted-by":"publisher","first-page":"e42893","DOI":"10.1371\/journal.pone.0042893","volume":"7","author":"HC He","year":"2012","unstructured":"He HC, Kashat L, Kak I, Kunavisarut T, Gundelach R, Kim D, et al. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS ONE. 2012;7(9):e42893. https:\/\/doi.org\/10.1371\/journal.pone.0042893.","journal-title":"PLoS ONE"},{"key":"14034_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/1471-2407-10-331","volume":"10","author":"R Ralhan","year":"2010","unstructured":"Ralhan R, Cao J, Lim T, Macmillan C, Freeman JL, Walfish PG. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis. BMC Cancer. 2010;10:331. https:\/\/doi.org\/10.1186\/1471-2407-10-331.","journal-title":"BMC Cancer"},{"key":"14034_CR21","doi-asserted-by":"publisher","first-page":"791970","DOI":"10.3389\/fendo.2021.791970","volume":"12","author":"Y Guang","year":"2021","unstructured":"Guang Y, He W, Zhang W, Zhang H, Zhang Y, Wan F. Clinical study of ultrasonographic risk factors for central lymph node metastasis of papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021;12:791970. https:\/\/doi.org\/10.3389\/fendo.2021.791970.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"14034_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/CH-180454","volume":"72","author":"J Zhan","year":"2019","unstructured":"Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in participants with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019;72(1):61\u201373. https:\/\/doi.org\/10.3233\/CH-180454.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"10","key":"14034_CR23","doi-asserted-by":"publisher","first-page":"e0139021","DOI":"10.1371\/journal.pone.0139021","volume":"10","author":"W Sun","year":"2015","unstructured":"Sun W, Lan X, Zhang H, Dong W, Wang Z, He L, Zhang T, Liu S. Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: A systematic review and Meta-Analysis. PLoS ONE. 2015;10(10):e0139021. https:\/\/doi.org\/10.1371\/journal.pone.0139021.","journal-title":"PLoS ONE"},{"issue":"4","key":"14034_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1210\/jc.2012-4072","volume":"98","author":"SY Nam","year":"2013","unstructured":"Nam SY, Shin JH, Han BK, Ko EY, Ko ES, Hahn SY, Chung JH. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J Clin Endocrinol Metab. 2013;98(4):1476\u201382. https:\/\/doi.org\/10.1210\/jc.2012-4072.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"14034_CR25","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1016\/j.ultrasmedbio.2015.02.018","volume":"41","author":"KN Park","year":"2015","unstructured":"Park KN, Kang KY, Hong HS, Jeong HS, Lee SW. Predictive value of estimated tumor volume measured by ultrasonography for occult central lymph mode metastasis in papillary thyroid carcinoma. Ultrasound Med Biol. 2015;41(11):2849\u201354. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2015.02.018.","journal-title":"Ultrasound Med Biol"},{"key":"14034_CR26","doi-asserted-by":"publisher","unstructured":"Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587\u201395. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046.","DOI":"10.1016\/j.jacr.2017.01.046"},{"key":"14034_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fonc.2020.00436","volume":"10","author":"S Xue","year":"2020","unstructured":"Xue S, Han Z, Lu Q, Wang P, Chen G. Clinical and ultrasonic risk factors for lateral lymph node metastasis in papillary thyroid microcarcinoma: A systematic review and Meta-Analysis. Front Oncol. 2020;10:436. https:\/\/doi.org\/10.3389\/fonc.2020.00436.","journal-title":"Front Oncol"},{"key":"14034_CR28","doi-asserted-by":"publisher","first-page":"108801","DOI":"10.1016\/j.ejrad.2019.108801","volume":"123","author":"L Jianming","year":"2020","unstructured":"Jianming L, Jibin L, Linxue Q. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: significant role of HBME-1. Eur J Radiol. 2020;123:108801. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108801.","journal-title":"Eur J Radiol"},{"issue":"1","key":"14034_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7863\/ultra.34.1.19","volume":"34","author":"J Ren","year":"2015","unstructured":"Ren J, Liu B, Zhang LL, Li HY, Zhang F, Li S, Zhao LR. A taller-than-wide shape is a good predictor of papillary thyroid carcinoma in small solid nodules. J Ultrasound Med. 2015;34(1):19\u201326. https:\/\/doi.org\/10.7863\/ultra.34.1.19.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"14034_CR30","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.21873\/invivo.12014","volume":"34","author":"KD Papapostolou","year":"2020","unstructured":"Papapostolou KD, Evangelopoulou CC, Ioannidis IA, Kassi GN, Morfas KS, Karaminas NI, et al. Taller-than-wide thyroid nodules with microcalcifications are at high risk of malignancy. Vivo. 2020;34(4):2101\u201305. https:\/\/doi.org\/10.21873\/invivo.12014.","journal-title":"Vivo"},{"issue":"2","key":"14034_CR31","first-page":"429","volume":"60","author":"EC Andriescu","year":"2019","unstructured":"Andriescu EC, Giu\u015fc\u0103 SE, Ciobanu Apostol DG, Lozneanu L, C\u0103runtu ID. EpCAM (MOC-31)- immunohistochemical profile and clinico-pathological correlations in different histological variants of papillary thyroid carcinoma. Rom J Morphol Embryol. 2019;60(2):429\u201336.","journal-title":"Rom J Morphol Embryol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14034-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:18:44Z","timestamp":1761135524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14034"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14034-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Medical Ethics Committee of Chinese PLA General Hospital. Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"803"}}